Bogle Grant C. 4

What Happened

• Grant C. Bogle, a director of Nuvalent, Inc. (NUVL), received an award of 3,444 restricted stock units (RSUs) on June 16, 2026. The RSUs were reported at $0 on the Form 4 (award/acquisition code A). RSUs convert to one share of Nuvalent Class A common stock per unit upon vesting; no cash was paid.

Key Details

• Transaction date: 2026-06-16; Form 4 filed 2026-06-18 (appears timely).
• Transaction type/code: Award/Grant (A).
• Shares/units granted: 3,444 RSUs; reported acquisition price $0 (typical for RSU grants).
• Vesting: RSUs vest in full on the earlier of June 16, 2027 or Nuvalent’s next annual meeting, subject to continued service (see footnote).
• Shares owned after transaction: Not disclosed in the provided excerpt of the filing.
• Footnote: Each RSU equals the right to one share of Class A common stock; full vesting contingent on continued service.

Context

• RSU grants are compensation awards, not open-market purchases or sales. They do not require an immediate cash outlay and do not represent an immediate sale of shares. Such grants are routine director/employment compensation and should be interpreted as part of pay, not a direct market signal.